| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
primed
alveolar macrophages from atopic asthmatic subjects
a Lung Research
Group, University of Bristol, Medical School Unit, Southmead Hospital,
Westbury on Trym, Bristol BS10 5NB, UK, b Department of Otorhinolaryngology
Correspondence to: Dr A Millar email:Ann.Millar{at}bristol.ac.uk
Received 4 February 2000; Returned to authors 6 April 2000; Revised version received 28 June 2000; Accepted for publication 3 July 2000
BACKGROUND
Asthma is
characterised pathologically by an inflammatory pulmonary infiltrate
rich in T helper (Th) 2 cells and eosinophils. Interleukin (IL)-12 is a
heterodimeric cytokine critical for driving the development of
uncommitted Th cells to express a Th 1 phenotype. Reduced pulmonary
production of IL-12 may therefore play a role in the pathogenesis of
asthma by contributing to the pulmonary cytokine imbalance seen in asthma.
METHODSIL-12 p70
protein levels in bronchoalveolar lavage fluid and p70 protein levels
and IL-12 messenger RNA in alveolar macrophage cultures from normal and
atopic asthmatic subjects were measured.
RESULTSThere was a
significant difference between the mean IL-12 p70 protein level in the
bronchoalveolar lavage fluid from asthmatic subjects (37.5 pg/ml) and
from normal subjects (131 pg/ml, p = 0.04). Alveolar macrophages from
asthmatic subjects produced significantly less IL-12 protein
(30 pg/ml) and messenger RNA than those from normal subjects
(69.5 pg/ml, p<0.005). These differences were not caused by
inhibition of IL-12 production by IL-10 nor to generalised hyporesponsiveness of asthmatic alveolar macrophages from subjects to
the effects of interferon (IFN)-
.
CONCLUSIONSPulmonary
IL-12 production is lower in asthmatic subjects. This reduction is not
the result of generalised hyporesponsiveness to IFN-. Reduced IL-12
levels may contribute to the development of asthmatic pulmonary
inflammation through dysregulation of Th cell development.
This article has been cited by other articles:
|
|
 |
|
  T. S. Hallstrand, E. Y. Chi, A. G. Singer, M. H. Gelb, and W. R. Henderson Jr. Secreted Phospholipase A2 Group X Overexpression in Asthma and Bronchial Hyperresponsiveness Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1072 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Peters-Golden The Alveolar Macrophage: The Forgotten Cell in Asthma Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 3 - 7. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
